- Category
- Micro (2022-23)
- Udyam number
- UDYAM-MH-18-0164345

Myeliyon Pharmaceutical Private Limited
About Myeliyon Pharmaceutical Private Limited
Data last updated:
Myeliyon Pharmaceutical Private Limited is a private limited company based in Mumbai, Maharashtra, India. It operates in the pharmaceutical retail and distribution segment of the pharmaceuticals sector. It was incorporated on 27 October 2018 and has been in existence for over 8 years.
The company is registered with the Registrar of Companies (ROC), Mumbai, under CIN U24299MH2018PTC316442. Its GSTIN is 27AAMCM1964E1ZB (Maharashtra).
The company has an authorised share capital of ₹40 Lakh and a paid-up capital of ₹30 Lakh. It is led by directors including Karunakar Kotian Bhoja and Ramesh Poojary Sanjeeva.
Its last annual general meeting (AGM) was held on 30 November 2021, and its latest financial statements are for the year ended 31 March 2021. The registered office is at Gala – 05 Samudra Snakcks Corner Shantaram Pad Khot Kuwa Rd Malad(E) Nr Bhalu Bai, Mumbai, Maharashtra, India – 400097.
As per the financials filed for FY 2021, the company reported a revenue of ₹21.42 Lakh, a growth of 8% compared to the previous year. For the same year it recorded a net loss of ₹32.15 Lakh (net margin -150.1%) and EBITDA of -₹38.28 Lakh (EBITDA margin -178.8%).
As per MCA filings, the company has open charges of ₹1.5 Cr on record. Court records list 1 case involving the company, including 1 filed against it; 1 case is pending.
Myeliyon Pharmaceutical Private Limited is registered as a micro enterprise under the Udyam registration framework (Reg. No. UDYAM-MH-18-0164345).
Company details
Recognitions & Rankings of Myeliyon Pharmaceutical
Contact details
Myeliyon Pharmaceutical Private Limited's registered office is in Mumbai, Maharashtra. Its e-mail address and telephone number are in the company report.
- Email
- Telephone
- Registered AddressGala – 05 Samudra Snakcks Corner Shantaram Pad Khot Kuwa Rd Malad(E) Nr Bhalu Bai, Mumbai, Maharashtra, India – 400097
- IndustryPharma, Pharmaceutical Retailers & Distributors
To see the full contact details of Myeliyon Pharmaceutical Private Limited, buy the company report.
- Company details, directors and signatories
- Historical financials and ratios
- Shareholding pattern and group structure
- Charges with holder and property details
- Legal cases, compliance and MCA filings
Business activity
The main business activity of Myeliyon Pharmaceutical is trade. In detail, this covers wholesale trading.
| Main activity group code | Main activity | Business activity code | Business activity | Share of turnover |
|---|---|---|---|---|
| G | Trade | G1 | Wholesale Trading |
To see the full business activity and turnover split of Myeliyon Pharmaceutical Private Limited, buy the company report.
Financials of Myeliyon Pharmaceutical Private Limited
FY 2021 filings availableMyeliyon Pharmaceutical Private Limited reported revenue of ₹21.42 Lakh (up 8% YoY) for FY 2021.
Compounded Annual Growth Rate (CAGR)
Revenue rose 8% in the latest year. EBITDA fell 43% in the latest year. All are worked out from the filed statements.
Financial Statement Summary
| Metrics | FY 2020-21 | FY 2019-20 | FY 2018-19 |
|---|---|---|---|
| Profit and Loss Statement | |||
| Revenue from Operations | |||
| Other Income | |||
| Total Revenue | |||
| Cost of Materials Consumed | |||
| Employee Benefit Expense | |||
| Finance Costs | |||
| Depreciation and Amortisation | |||
| Other Expenses | |||
| Total Expenses | |||
| EBITDA | -₹38.28 Lakh | ||
| Profit Before Tax | |||
| Tax Expense | |||
| Net Profit (PAT) | -₹32.15 Lakh | ||
| Balance Sheet | |||
| Share Capital | |||
| Reserves and Surplus | |||
| Net Worth (Total Equity) | |||
| Long-term Borrowings | |||
| Short-term Borrowings | |||
| Trade Payables | |||
| Total Liabilities | |||
| Fixed Assets | |||
| Investments | |||
| Inventories | |||
| Trade Receivables | |||
| Cash and Bank Balance | |||
| Total Assets | |||
Financial Ratios
| Metrics | FY 2020-21 | FY 2019-20 | FY 2018-19 |
|---|---|---|---|
| Profitability | |||
| EBITDA Margin | -178.8% | ||
| Net Profit Margin | -150.1% | ||
| Return on Equity (ROE) | |||
| Return on Capital Employed (ROCE) | |||
| Return on Assets (ROA) | |||
| Liquidity and Debt | |||
| Current Ratio | |||
| Quick Ratio | |||
| Debt-to-Equity Ratio | |||
| Interest Coverage Ratio | |||
| Efficiency and Growth | |||
| Asset Turnover | |||
| Receivable Days | |||
| Payable Days | |||
| Inventory Days | |||
| Revenue Growth | |||
| Net Profit Growth | |||
To see the full financial statements and ratios of Myeliyon Pharmaceutical Private Limited, buy the company report.
Board of directors of Myeliyon Pharmaceutical Private Limited
Myeliyon Pharmaceutical has 3 directors on record. No former directors are listed.
| Name | Designation | Appointment Date | Tenure | Status |
|---|---|---|---|---|
| Syed Moiz U Zafer | Additional Director | 30 Aug 2019 | 7 Years 2 Months | Current |
| Karunakar Kotian Bhoja | Director | 27 Oct 2018 | 8 Years 0 Months | Current |
| Ramesh Poojary Sanjeeva Also directs: Gabgal Neelu Son Private Limited | Director | 27 Oct 2018 | 8 Years 0 Months | Current |
Peer comparison
Myeliyon Pharmaceutical Private Limited is compared with the 5 companies closest to it by revenue in the Healthcare industry (Medical Consumables, Pharma Retail and Distribution), with the same principal business activity (wholesale trading), from the latest filed financials of each company.
| Company | Revenue | Net profit | Margin | Growth (1 yr) | Employees | Location |
|---|---|---|---|---|---|---|
| Medigrowth Pharmaceuticals Private Limited | ₹21.48 Lakh (FY 2023) | 64.0% | Navi Mumbai, Maharashtra, India | |||
| J. K. Lifescience Private Limited | ₹21.42 Lakh (FY 2025) | -27.0% | Silvassa, Dadra and Nagar Haveli, India | |||
| Myeliyon Pharmaceutical Private Limitedthis company | ₹21.42 Lakh (FY 2021) | -₹32.15 Lakh | -150.1% | 8.0% | Mumbai, Maharashtra, India | |
| Anitra Distributors Private Limited | ₹21.3 Lakh (FY 2019) | 266.0% | Puthur, Kerala, India | |||
| Allwell Remedies Private Limited | ₹21.27 Lakh (FY 2019) | Delhi, India | ||||
| Pyrocare Pharmaceuticals Private Limited | ₹21.26 Lakh (FY 2021) | -28.0% | Patna, Bihar, India |
To see the full peer comparison of Myeliyon Pharmaceutical Private Limited, buy the company report.
Auditor
Myeliyon Pharmaceutical Private Limited is audited by DEEPAK SHUKLA & ASSOCIATES for the financial year 2020.
| Auditor firm | Financial year | Firm registration number |
|---|---|---|
| DEEPAK SHUKLA & ASSOCIATES | FY 2020 | 021993C |
Shareholding
The shareholding of Myeliyon Pharmaceutical Private Limited is on record for FY 2020, split between promoters, domestic institutions, public shareholders and others.
| Shareholder category | FY 2020 |
|---|---|
| Promoters | |
| Domestic institutional investors (DII) | |
| Public | |
| Others |
To see the full shareholding pattern of Myeliyon Pharmaceutical Private Limited, buy the company report.
Charges & borrowings
| Date | Charge ID | Lender | Amount | Status | Modified or satisfied on |
|---|---|---|---|---|---|
| 11 Mar 2020 | 100332383 | Indian Bank | ₹1.5 Cr | Open |
Total charge records: 1 View all charges
Legal cases
Myeliyon Pharmaceutical Private Limited has 1 court case on record: 1 filed against it. All case is pending.
Cases by court
| Court | Cases | Against the company | Pending |
|---|---|---|---|
| District courts | 1 | 1 | 1 |
Cases on record (1 of 1)
| Court | Type of case | Party | Status |
|---|---|---|---|
| District court, Mumbai CMM Courts, Maharashtra | Interim or miscellaneous application | Filed against the company by an individual | Pending |
To see the full case history of Myeliyon Pharmaceutical Private Limited, buy the company report.
Case records are compiled from court listings and may lag the court's own records. A case filed against a company is not a finding against it.
MSME payment delays
No delayed payments to MSME suppliers are on our record for Myeliyon Pharmaceutical Private Limited; the supplier-wise MSME Form 1 check is in the company report Buy the company report.
GST
Myeliyon Pharmaceutical has 1 GST registration: 1 active.
| GSTIN | State | Status | Registered on |
|---|---|---|---|
| 27AAMCM1964E1ZB | Maharashtra | Active | 15 Feb 2019 |
To see the full GST registrations and return filing status of Myeliyon Pharmaceutical Private Limited, buy the company report.
Recent activity
Myeliyon Pharmaceutical Private Limited has 3 board changes on record since 2018: 3 appointments. The latest: Syed Moiz U Zafer was appointed as Additional Director on 30 Aug 2019.
Frequently asked questions
Myeliyon Pharmaceutical is an active private limited company based in Mumbai, Maharashtra, India. The company works in pharmaceutical retailers and distributors, within the pharma industry. It was incorporated on 27 October 2018 (8+ years old) and is registered under CIN U24299MH2018PTC316442.
Myeliyon Pharmaceutical has 3 current directors:
- Syed Moiz U Zafer - Additional Director
- Karunakar Kotian Bhoja - Director
- Ramesh Poojary Sanjeeva - Director
The latest financial statements of Myeliyon Pharmaceutical on record with the MCA are for the year ended 31 March 2021. Its last annual general meeting was held on 30 November 2021. Year-wise statements from FY 2019 are in the company report.
The GSTIN of Myeliyon Pharmaceutical is 27AAMCM1964E1ZB, registered in Maharashtra.
The CIN (Corporate Identification Number) of Myeliyon Pharmaceutical is U24299MH2018PTC316442. It is issued by the Ministry of Corporate Affairs under the Companies Act, 2013, and uniquely identifies the company in India.
Myeliyon Pharmaceutical has 1 court case on record: 1 filed against it. 1 is pending.
Myeliyon Pharmaceutical was incorporated on 27 October 2018, making it 8+ years old. It is registered with the Registrar of Companies, Mumbai.
The peers of Myeliyon Pharmaceutical by revenue are Medigrowth Pharmaceuticals Private Limited, J. K. Lifescience Private Limited, Anitra Distributors Private Limited, Allwell Remedies Private Limited, Pyrocare Pharmaceuticals Private Limited, all in the Healthcare industry (Medical Consumables, Pharma Retail and Distribution), with the same principal business activity (wholesale trading).
Syed Moiz U Zafer was appointed as Additional Director on 30 Aug 2019. Karunakar Kotian Bhoja was appointed as Director on 27 Oct 2018. Ramesh Poojary Sanjeeva was appointed as Director on 27 Oct 2018.
Yes, Myeliyon Pharmaceutical is registered as a micro enterprise under Udyam registration (number: UDYAM-MH-18-0164345).
The registered office of Myeliyon Pharmaceutical is at Gala – 05 Samudra Snakcks Corner Shantaram Pad Khot Kuwa Rd MaladE Nr Bhalu Bai, Mumbai, Maharashtra, India – 400097.

